ImmuCell Corp (ICCC, Financial)(30-Year Financial) files //www.sec.gov/Archives/edgar/data/811641/000121390020007650/0001213900-20-007650-index.htm'' rel='nofollow' target='_blank'>its latest 10-K with SEC for the fiscal year ended on December 31, 2019. ImmuCell Corp is engaged in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include First Defense, Wipe Out Dairy Wipes and CMT. ImmuCell Corp has a market cap of $32.371 million; its shares were traded at around $4.49 with and P/S ratio of 2.14. GuruFocus has detected 3 severe warning signs with ImmuCell Corp. .
For the last quarter ImmuCell Corp reported a revenue of $3.63 million, compared with the revenue of $2.94 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $13.7 million, an increase of 24.9% from last year. For the complete 30-year financial data, please go here.. For the last five years ImmuCell Corp had an average revenue growth rate of 9.8% a year.
The reported loss per diluted share was 19 cents for the year. The ImmuCell Corp had an operating margin of -6.95%, compared with the operating margin of -19.54% a year before. The 10-year historical median operating margin of ImmuCell Corp is -2.52%. The profitability rank of the company is 4 (out of 10).
At the end of the fiscal year, ImmuCell Corp has the cash and cash equivalents of $8.77 million, compared with $2.52 million in the previous year. The company had no long term debt, compared with $8.42 million in the previous year. The interest coverage to the debt is at a comfortable level of 98. ImmuCell Corp has a financial strength rank of 6 (out of 10).
At the current stock price of $4.49, ImmuCell Corp is traded at 15.3% discount to its historical median P/S valuation band of $5.30. The P/S ratio of the stock is 2.14, while the historical median P/S ratio is 2.49. The stock lost 24.03% during the past 12 months.
Directors and Officers Recent Trades:
- Director David Cunningham bought 2,000 shares of ICCC stock on 03/12/2020 at the average price of $4. The price of the stock has increased by 12.25% since.
- Director David Scott Tomsche bought 4,600 shares of ICCC stock on 03/11/2020 at the average price of $4.28. The price of the stock has increased by 4.91% since.
For the complete 20-year historical financial data of ICCC, click here.